Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Selective Alpha Blockers (Silodosin) in Management of Lower Ureteral Stones Larger Than 6 mm in Diameter

NCT06381206 is registered in ClinicalTrials.gov with Syrian Private University as lead sponsor.

NCT NCT06381206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06381206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Selective Alpha Blockers (Silodosin) in Management of Lower Ureteral Stones Larger Than 6 mm in Diameter
Lead sponsor
Syrian Private University
Phase
Phase 1/2
Overall status
Completed
Start date
October 20, 2022
Completion date
October 25, 2023
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stone, kidney